India, Nov. 30 -- Pune-based startup Mylab has received CDSCO, TB Expert Committee and ICMR approval for first Made in India tuberculosis (TB) detection kit which simultaneously detects multiple drug resistance to Rifampicin (RIF) and Isoniazid (INH) in single test.

The kit named PathoDetect MTB RIF and INH drug resistance kitis a RT-PCR based kit for accurate detection and will be used with Mylab Compact device systems , which will allow completely automated testing of multiple samples within 2 hours.

Explaining how this kit gives better testing option for TB, Hasmukh Rawal, MD of Mylab said, "We are addressing several problems simultaneously here. First being able to speed up testing by automated systems that can do multiple tests at ...